Novel fully human anti-VAP-1 monoclonal antibodies

Details for Australian Patent Application No. 2008240560 (hide)

Owner Biotie Therapies Corporation

Inventors Vainio, Jani; Vainio, Petri; Smith, David; Mikkola, Jari; Vuorio, Paivi

Agent Shelston IP

Pub. Number AU-B-2008240560

PCT Pub. Number WO2008/129124

Priority 20075278 20.04.07 FI; 60/907,904 20.04.07 US

Filing date 17 April 2008

Wipo publication date 30 October 2008

Acceptance publication date 17 May 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/129124 Priority application(s): WO2008/129124

17 May 2012 Application Accepted

  Published as AU-B-2008240560

13 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008240564-Method of directing drilling pattern in curved tunnels, rock drilling rig, and software product

2008240545-Nanoparticles comprising a cyclodextrin and a biologically active molecule and uses thereof